Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Preventice Solutions, founded in 2004 and headquartered in Eagan, Minnesota, is a leading provider of digital healthcare solutions and remote cardiac monitoring services. The company has established itself as an innovative player in the healthcare technology sector, offering cutting-edge solutions to improve patient care and outcomes.
On January 21st, 2021, Preventice Solutions was acquired by Boston Scientific, a global medical technology leader, in a deal valued between $925 million and $1.225 billion. This acquisition highlights the company's significant growth and market potential in the digital health space. Prior to the acquisition, Preventice Solutions had raised a total of $137 million in funding, demonstrating strong investor interest in its technology and business model.
Given the recent acquisition by Boston Scientific, it is unlikely that Preventice Solutions will pursue an initial public offering (IPO) in the near future. As a subsidiary of a publicly-traded company, Preventice Solutions' financial performance and growth will likely be reflected in Boston Scientific's stock performance.
For investors interested in gaining exposure to Preventice Solutions' technology and market potential, considering investment opportunities in Boston Scientific (NYSE: BSX) may be a viable option. However, it's important to note that individual investment decisions should be based on thorough research and consultation with financial advisors.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Preventice Solutions' IPO prospects remain uncertain, investors interested in the healthcare technology sector don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential leaders in the medical device and digital health space, with lower minimum investments than traditional private equity opportunities. By leveraging our expertise, you can diversify your portfolio with pre-IPO investments in innovative companies like Preventice Solutions, potentially benefiting from their growth before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
